Published in

Royal Society of Chemistry, Journal of Materials Chemistry B: Materials for biology and medicine, 9(7), p. 1503-1509, 2019

DOI: 10.1039/c8tb03188f

Links

Tools

Export citation

Search in Google Scholar

Nanomized tumor-microenvironment-active NIR fluorescent prodrug for ensuring synchronous occurrences of drug release and fluorescence tracing

Journal article published in 2019 by Qiang Li, Jun Cao, Qi Wang ORCID, Jie Zhang, Shiqin Zhu, Zhiqian Guo, Wei-Hong Zhu ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

A nanomized NIR fluorescent prodrug was developed with improved bioavailability and tumor-targeting ability. Nanomized tumor-microenvironment-active NIR DCM-S-GEM/PEG prodrug provides a novel approach to realize long real-time tracking of drug delivery and activation process without systemic toxicity in vivo.